Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CAPPS VICKIE L
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Simson Jake
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Barrett Ronald W
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gujrathi Sheila
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kung Winston
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director McNulty Alana B.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lichter Jay
Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D.(14.1%),Tighe Reardon(8.5%), etc.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lichter Jay
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reardon Tighe
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Avalon Ventures XI, L.P.
Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(19.99%),Peter Kolchinsky(19.99%), etc.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D.(17.1%),Tighe Reardon(10.4%), etc.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Avalon Ventures XI, L.P.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gujrathi Sheila
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CAPPS VICKIE L
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(0%),Oleg Nodelman(0%), etc.
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(6.8%),Citadel Advisors Holdings LP(6.8%), etc.
No Data